18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Status:
Not yet recruiting
Trial end date:
2029-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore whether 18F-FDG PET/CT guided reduced-dose
radiotherapy would maintain survival outcomes in nasopharyngeal carcinoma (NPC) patients.
Phase:
Phase 2
Details
Lead Sponsor:
Taizhou Hospital
Collaborators:
Taizhou Cancer Hospital Taizhou Central Hospital Taizhou Enze Medical Center (Group) Enze Hospital